Lungvision
Payments companies reported to CMS as associated with Lungvision. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lungvision, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lungvision
These are the largest totals companies reported as associated with Lungvision. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Wilson Tsai | Walnut Creek, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $12,379.94 |
| Joseph Cicenia | Cleveland, OH | Pulmonary Disease | $12,142.36 |
| Michael Machuzak | Cleveland, OH | Pulmonary Disease | $4,543.39 |
| Sonali Sethi | New York, NY | Pulmonary Disease | $3,805.51 |
| Sean Stoy | Robbinsdale, MN | Pulmonary Disease | $2,515.88 |
| Nina Maouelainin | Lansdale, PA | Pulmonary Disease | $2,200.00 |
| Shaheen Islam | Augusta, GA | Pulmonary Disease | $1,585.63 |
| Lisa Olson | Saint Paul, MN | Registered Nurse | $1,535.07 |
| Omar Sheriff | Sarasota, FL | Internal Medicine | $1,331.43 |
| Douglas Hogarth | Chicago, IL | Pulmonary Disease | $1,318.51 |
Prescribed Lungvision?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.